Ascentage Pharma Group International (AAPG) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and thank you for standing by. Welcome to the Ascentage Pharma 2025 interim results presentation and conference call. At this time all participants are in listen only mode. After the speaker's presentation there will be the question and answer session. To ask a question during the session you need to press star 1 1 on your telephone keypad. You will hear an automatic message advising your hand is raised. To withdraw a question please press star 1 and 1 again. Please be advised that today's conference has been recorded. I would now like to hand the conference over to our first speaker today, Hogan Wang. Please go ahead, sir. Thank you, operator. Good morning and welcome to today's call. As a reminder, the company's remarks today corresponds with the earnings release that was issued on August 20th evening U.S. Eastern Time. In addition, recording of today's call and the PowerPoint presentation will remain available on the Centage website within the investor relations section shortly following the conclusion of this call. As part of today's call, I'll go over some of the Sage Harbor statements. We'll be making certain forward-looking statements based on our current expectations. These statements are subject to numerous and uncertainties that may cause actual results to differ materially from what we expect due to a variety of factors, including those discussed in our SDC filings, including 20F. Should any of these risks materialize, then the assumption may be proven to be incorrect and the actual results may vary from what was mentioned in the forward-looking statement. On today's call, I'm joined by Dr. Da Jun Yang, Chairman and CEO, who is going to provide an overview of recent developments and performance for the first half of 2025, as well as Dr. Veet Mishr...